期刊文献+

山莨菪碱联合血浆置换治疗血栓性血小板减少性紫癜患者血浆D-二聚体变化的意义 被引量:1

To analyze the variation of plasma D-dimer in the process of anisodamine combined with plasma exchange treatment of thrombotic thrombocytopenic purpura
下载PDF
导出
摘要 目的探讨山莨菪碱(Ani)联合血浆置换(PE)治疗血栓性血小板减少性紫癜(TTP)患者血浆D-二聚体(D-D)的变化,从而了解Ani在TTP的治疗中纤溶亢进改善情况。方法选择68例TTP病人随机分成两组,每组34例。联合干预组给予Ani联合TPE治疗,而对照组只给予以PE治疗,疗程均21d。检测治疗前和治疗后2,5,10,16,21d两组血浆D-D数值变化。结果 2组治疗的第2d,差异无显著性(P>0.05),但联合干预组在治疗的第5,10,16,21d与对照组相比有显著性差异(P<0.05)。两组疗效的观察,联合干预组有效率为97.1%,对照组有效率为79.4%,2组的总疗效有显著性差异(P<0.05)。结论 Ani联合TPE能加快TTP患者血浆D-D数值的下降,有利于患者的预后恢复。 Objective To observe the variation of plasma D-dimer(D- D) and investigate the improvement of the hyperfibrinolysis and the clinic efficacy of plasma exchange (PE) combined with anisodamine(Ani) in the treatment of thrombotic thrombocytopenic purpura (TTP). Methods 68 patients were randomized into two groups,each group contained 34 patients. The treatment group was given Ani injection combined with PE,the controlled group was just given PE, with a same course of 21 days duration. Observe the efficacy of the two groups, and the variation of plasma D-D was observed in the period of 2,5,10,16,21 days after the treatment. Results There was no difference between the two groups in 2 days' therapy (P〉0.05). However there were significant differences (P〈0.05) in 2,5,10,16,21 days. The efficacy of the treatment group after 21 days is 97. 1%, the controlled group is 79. 4%, there were significant differences between the two groups (P〈0.05). Conclusion Ani combined with PE shows better clinic effect and the D- D descends faster than PE alone in therapy of TTP.
出处 《中国实验诊断学》 2013年第9期1637-1639,共3页 Chinese Journal of Laboratory Diagnosis
基金 唐山市科学技术研究与发展计划课题(05134608a)
关键词 血浆D-二聚体 血栓性血小板减少性紫癜 山莨菪碱 血浆置换 Plasma D-dimer Thrombotic thromboeytopenic purpura Anisodamine Therapeutic plasma exchange
  • 相关文献

参考文献10

二级参考文献33

  • 1刘春红,王宏,马雅静.纤维蛋白原对缺血性脑卒中的影响[J].中国动脉硬化杂志,2004,12(4):477-478. 被引量:14
  • 2潘力雄,姚志彬,陈以慈.c-fos蛋白在大鼠脑缺血再灌流海马中的表达及其与黄连素抗脑缺血的关系[J].中华实验外科杂志,1996,13(1):57-57. 被引量:3
  • 3许冬梅,孙怀军,李昆,冷文萍,王忻,季占胜.短暂性脑缺血发作发展至脑梗死危险因素的分析[J].临床神经病学杂志,2006,19(3):207-209. 被引量:35
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33008
  • 5Johnston SC,Rothwell PM,Nguyen-Huynh MN,et al.Validation and refinement of scores to predict very early strock risk after transient ischemicattack.Lancet,2007,369(9558):283-292.
  • 6Albucher JF,Martel P,Mas JL.Clinical practice guidelines:diagnosis and immediate management of transient ischemic attacks in adults.Cerebrovasc Dis,2005,20(4):220-225.
  • 7Tsivgoulis G,Spengos K,Manta P,et al.Validation of the ABCD score in identifying individuals at high early risk of strock after a transientischemic attack:a hospital-based case series study.Stroke,2006,37(12):2892-2897.
  • 8Turaj W,Slowik A,Dziedzic T,et al.Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic strock.J Neurol Sci,2006,246(1 /2):13-19.
  • 9Johnson EM Jr, Greenlund LJ, Akins PT, et al.Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury[J].J Neurotrauma, 1995, 12(5):843-852.
  • 10Sabbah HN, Sharov VG. Apoptosis in heart failure[J].Preg Cardiovasc Dis,1998,40(6):549-562.

共引文献52

同被引文献20

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部